Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, JH | - |
dc.contributor.author | Lee, KS | - |
dc.contributor.author | Kang, YK | - |
dc.contributor.author | Yoo, KH | - |
dc.contributor.author | Shin, KJ | - |
dc.contributor.author | Kim, DC | - |
dc.contributor.author | Kong, JY | - |
dc.contributor.author | Lee, YH | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Kim, DJ | - |
dc.date.accessioned | 2024-01-21T07:43:29Z | - |
dc.date.available | 2024-01-21T07:43:29Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2003-12-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/137999 | - |
dc.description.abstract | The synthesis and antibacterial activity of novel 1beta-methylcarbapenems 1a-f bearing oxyiminopyrrolidinylamide moiety at C-5 position of pyrrolidine are described. Most compounds exhibited comparable antibacterial activity to meropenem against a wide range of Gram-positive and Gram-negative organisms including Pseudomonas aeruginosa isolates. Of these carbapenems, 1a showed potent and broad spectrum of antibacterial activity and similar stability to DHP-I to meropenem. Against clinical isolates of 40 Gram-negative bacterial species including MDR and ESBL-producing strains, the selected carbapenem 1a possessed excellent in vitro activity except for MDR P. aeruginosa, and was comparable in potency to meropenem. (C) 2003 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | ANTIBACTERIAL ACTIVITY | - |
dc.title | Synthesis and biological activity of novel 1 beta-methylcarbapenems with oxyiminopyrrolidinylamide moiety | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2003.09.039 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.13, no.24, pp.4399 - 4403 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 24 | - |
dc.citation.startPage | 4399 | - |
dc.citation.endPage | 4403 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000187010700029 | - |
dc.identifier.scopusid | 2-s2.0-0344496008 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | ANTIBACTERIAL ACTIVITY | - |
dc.subject.keywordAuthor | 1β-methylcarbapenems | - |
dc.subject.keywordAuthor | oxyiminopyrrolidinylamide moiety | - |
dc.subject.keywordAuthor | DHP-I stability | - |
dc.subject.keywordAuthor | MDR & ESBL-producing strains | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.